Oleksii S Rukhlenko

10PUBLICATIONS
31CO-AUTHORS
Innate immunityMechanobiologyMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 17, 2026
IFN𝛾 and IFN𝛾 mimetics prevent IFN-I-mediated TB susceptibility by regulating iron metabolism and lipid peroxidation.

|Oct 02, 2025
Lipid peroxidation and type I interferon coupling fuels pathogenic macrophage activation causing tuberculosis susceptibility.

Shivraj M Yabaji, Vadim Zhernovkov, Prasanna Babu Araveti

|Jul 14, 2025
A structure-based modelling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia.

Luke Jones, Oleksii Rukhlenko, Tânia Dias

|Jan 03, 2025
cSTAR analysis identifies endothelial cell cycle as a key regulator of flow-dependent artery remodeling.

Hanqiang Deng, Oleksii S Rukhlenko, Divyesh Joshi

|Mar 18, 2024
Lipid Peroxidation and Type I Interferon Coupling Fuels Pathogenic Macrophage Activation Causing Tuberculosis Susceptibility.

Shivraj M Yabaji, Vadim Zhernovkov, Prasanna Babu Araveti

|Sep 27, 2023
Cell state transition analysis identifies interventions that improve control of Mycobacterium tuberculosis infection by susceptible macrophages.

Shivraj M Yabaji, Oleksii S Rukhlenko, Sujoy Chatterjee

Pageof 2

Frequent Collaborators

7 joint publications

Boris N Kholodenko

4 joint publications

Igor Kramnik

4 joint publications

Alexander A Gimelbrant

4 joint publications

Shivraj M Yabaji